Although mechanistic and in vivo breast cancer data remain limited, these findings indicate that alkaloids like berberine represent an additional class of phytochemicals capable of modulating HIF-1α–driven hypoxic responses. This evidence concerns the gene HIF1A and breast carcinoma.